<html>
<head>PUBMED IDs for TICAM-1</head>
<body bgcolor='#C5F0F2'><h1>TICAM-1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/12539043/'>TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.</a> January 23  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14519765/'>TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta.</a> October 2  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14960149/'>Transcriptional regulation of the human TRIF (TIR domain-containing adaptor protein inducing interferon beta) gene.</a> February 13  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/14993454/'>TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression.</a> March 3  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15226270/'>The cytoplasmic 'linker region' in Toll-like receptor 3 controls receptor localization and signaling.</a> July 1  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15618008/'>TICAM-1 and TICAM-2: toll-like receptor adapters that participate in induction of type 1 interferons.</a> December 25  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15710891/'>Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF.</a> February 16  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17142768/'>NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type I IFN induction.</a> December 5  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17239348/'>Inhibition of lipid A-mediated type I interferon induction by bactericidal/permeability-increasing protein (BPI).</a> January 24  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17521732/'>C-terminal LRRs of human Toll-like receptor 3 control receptor dimerization and signal transmission.</a> May 25  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17601575/'>Tumor immunotherapy using bone marrow-derived dendritic cells overexpressing Toll-like receptor adaptors.</a> July 3  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17947687/'>Differential type I IFN-inducing abilities of wild-type versus vaccine strains of measles virus.</a> October 20  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18450748/'>Homo-oligomerization is essential for Toll/interleukin-1 receptor domain-containing adaptor molecule-1-mediated NF-kappaB and interferon regulatory factor-3 activation.</a> May 3  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19669308/'>Increased expression of Toll-like receptor 3 in intrahepatic biliary epithelial cells at sites of ductular reaction in diseased livers.</a> June 1  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18611945/'>Soluble G protein of respiratory syncytial virus inhibits Toll-like receptor 3/4-mediated IFN-beta induction.</a> July 10  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19120474/'>Functional evolution of the TICAM-1 pathway for extrinsic RNA sensing.</a> July 31  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19506737/'>Pan-vertebrate toll-like receptors during evolution.</a> June 10  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20418377/'>A molecular mechanism for Toll-IL-1 receptor domain-containing adaptor molecule-1-mediated IRF-3 activation.</a> August 25  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20814227/'>Molecular basis for an attenuated cytoplasmic dsRNA response in human embryonic stem cells.</a> January 25  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20814219/'>Suppression of Par-4 protects human renal proximal tubule cells from apoptosis induced by oxidative stress.</a> June 18  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21071089/'>Strain-to-strain difference of V protein of measles virus affects MDA5-mediated IFN-Î²-inducing potential.</a> February 1  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21362440/'>Comparative and phylogenetic analyses of three TIR domain-containing adaptors in metazoans: implications for evolution of TLR signaling pathways.</a> August 19  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21998457/'>The TLR3/TICAM-1 pathway is mandatory for innate immune responses to poliovirus infection.</a> January 10  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/24311583/'>The TLR signalling adaptor TRIF/TICAM-1 has an N-terminal helical domain with structural similarity to IFIT proteins.</a> July 10  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24311551/'>Effects of a novel schizophrenia risk variant rs7914558 at CNNM2 on brain structure and attributional style.</a> September 10  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24377923/'>Assessment of the Toll-like receptor 3 pathway in endosomal signaling.</a> August 12  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24377923/'>Assessment of the Toll-like receptor 3 pathway in endosomal signaling.</a> August 12  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24532585/'>IPS-1 is essential for type III IFN production by hepatocytes and dendritic cells in response to hepatitis C virus infection.</a> May 16  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24788318/'>HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon.</a> June 16  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24905288/'>TLR3 mediated innate immune response in mice brain following infection with Chikungunya virus.</a> April 16  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26512676/'>Interferon (IFN) and Cellular Immune Response Evoked in RNA-Pattern Sensing During Infection with Hepatitis C Virus (HCV).</a> May 10  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/28564605/'>A TLR3-Specific Adjuvant Relieves Innate Resistance to PD-L1 Blockade without Cytokine Toxicity in Tumor Vaccine Immunotherapy.</a> June 1  2017<br></body></html>
